Injection fibrosis - PDFSEARCH.IO - Document Search Engine

Injection fibrosis
Results: 19

#	Item
1	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OMNISCAN safely and effectively. See full prescribing information for OMNISCAN. OMNISCANTM (gadodiamide) Injection f Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-11-17 14:53:23 Gadolinium Nephrogenic systemic fibrosis Magnetic resonance imaging MRI contrast agent Flucytosine Chemistry Matter Gadodiamide
2	OPTIMARK (gadoversetamide) injection Label Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-11-25 11:08:36 Medicine Nephrogenic systemic fibrosis Organochlorides Gadolinium Magnetic resonance imaging Renal failure Lorazepam Gadoversetamide MRI contrast agent Chemistry Nephrology Matter
3	Omniscan (gadodiamide) injection label Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2010-12-21 14:44:58 Nephrology Organ failure Gadodiamide Nephrogenic systemic fibrosis Gadolinium Magnetic resonance imaging Renal failure Renal function Acute kidney injury Anatomy Medicine Chemistry
4	Prohance (gadoteridol) injection label Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2010-12-21 14:29:00 Nephrogenic systemic fibrosis Nephrology Organic chemistry Gadoteridol Aspirin Ketorolac MRI contrast agent Gadodiamide Chemistry Non-steroidal anti-inflammatory drugs Medicine
5	Key Techniques to Reduce Severe Injection Site Reactions ® VIVITROL (naltrexone for extended-release injectable suspension) Intramuscular Injection • Use appropriate VIVITROL needle to ensure the injection reaches the Add to Reading List Source URL: www.vivitrolrems.com Language: English - Date: 2013-08-01 17:58:38 Dosage forms Medicine Injection Adipose tissue Subcutaneous injection Pen needles Injection fibrosis Pharmacology Pharmaceutical sciences Routes of administration
6	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EOVIST® Injection safely and effectively. See full prescribing information for EOVIST Injection. EOVIST (Gadoxetate Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-10-18 16:30:47 Nephrogenic systemic fibrosis Nephrology Gadolinium Lorazepam Magnetic resonance imaging MRI contrast agent Flucytosine Chemistry Matter Organochlorides
7	The recommended dose of Gadavist is 0.1 mL/kg body weight (0.1 mmol/kg), administered as an intravenous bolus injection at a flow rate of approximately 2 mL/second. Flush the intravenous cannula with physiological saline Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-10-18 16:38:58 Gadolinium Nephrogenic systemic fibrosis Magnetic resonance imaging Radiocontrast agent Ketorolac Lorazepam MRI contrast agent Cardiac MRI perfusion Chemistry Matter Gadodiamide
8	Multihance (gadobenate dimeglumine) injection label Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2010-12-21 13:20:36 Gadodiamide Nephrogenic systemic fibrosis Gadolinium Magnetic resonance imaging Lorazepam MRI contrast agent Cardiac MRI perfusion Chemistry Matter Medicine
9	OptiMARK™ 0.5 mmol/mL (Gadoversetamide Injection) PRESCRIBING INFORMATION Rx only Mallinckrodt Inc. May 2013 Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-05-23 16:04:28 Medicine MRI contrast agent Nephrogenic systemic fibrosis Gadolinium Magnetic resonance imaging Renal failure Gadoversetamide Chemistry Nephrology Matter
10	ProHance(8 Multipack™ (Gadoteridol) Injection, 279.3 mg/mL Pharmacy Bulk Package -...Page 1 of9 Prohance Multipack (gadoteridol) Injection, Solution (Bracco Diagnostics Inc. i Pharmacy Bulk Package - Not for Direct I Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-03-31 14:43:14 Gadodiamide Nephrogenic systemic fibrosis Gadopentetic acid Gadoteridol Gadolinium Magnetic resonance imaging Aspirin MRI contrast agent Chemistry Matter Medicine

UPDATE